KDM6B Histone Demethylase is an Epigenetic Regulator of Estrogen Receptor β Expression in Human Pleural Mesothelioma

References

• Robinson BW , MuskAW , LakeRA . Malignant mesothelioma . Lancet366 , 397 – 408 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Ismail-Khan R , RobinsonLA , WilliamsCCJr , GarrettCR , BeplerG , SimonGR . Malignant pleural mesothelioma: a comprehensive review . Cancer Control13 , 255 – 263 ( 2006 ).
   PubMedGoogle Scholar
• Tsao AS , WistubaI , RothJA , KindlerHL . Malignant pleural mesothelioma . J. Clin. Oncol.27 ( 12 ), 2081 – 2090 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Gilham C , RakeC , BurdettGet al. Pleural mesothelioma and lung cancer risks in relation to occupational history and asbestos lung burden . Occup. Environ. Med.73 ( 5 ), 290 – 299 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Surmont VF , van ThielER , VermaelenK , van MeerbeeckJP . Investigational approaches for mesothelioma . Front. Oncol.1 , 22 ( 2011 ).
   PubMedGoogle Scholar
• Schramm A , OpitzI , ThiesSet al. Prognostic significance of epithelial–mesenchymal transition in malignant pleural mesothelioma . Eur. J. Cardiothorac. Surg.37 ( 3 ), 566 – 572 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Porret E , MadelaineJ , Galateau-SalleF , BergotE , ZalcmanG . Epidemiology, molecular biology, diagnostic and therapeutic strategy of malignant pleural mesothelioma in 2007 – an update . Rev. Mal. Respir.24 , 6S157 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• van Zandwijk N , ClarkeC , HendersonDet al. Guidelines for the diagnosis and treatment of malignant pleural mesothelioma . J. Thorac. Dis.5 , E254 – E307 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Davidson B . Prognostic factors in malignant pleural mesothelioma . Hum. Pathol.46 ( 6 ), 789 – 804 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Pass HI . Biomarkers and prognostic factors for mesothelioma . Ann. Cardiothorac. Surg.1 ( 4 ), 449 – 456 ( 2012 ).
   PubMedGoogle Scholar
• Pinton G , BrunelliE , MurerBet al. Estrogen receptor-beta affects the prognosis of human malignant mesothelioma . Cancer Res.69 ( 11 ), 4598 – 4604 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Manente AG , ValentiD , PintonGet al. Estrogen receptor β activation impairs mitochondrial oxidative metabolism and affects malignant mesothelioma cell growth in vitro and in vivo . Oncogenesis02 , e72 ( 2013 ).
   Google Scholar
• Manente AG , PintonG , ZoncaSet al. Intracellular lactate-mediated induction of estrogen receptor beta (ERβ) in biphasic malignant pleural mesothelioma cells . Oncotarget06 ( 28 ), 25121 – 25134 ( 2015 ).
   Google Scholar
• Kaelin WG Jr , RatcliffePJ . Oxygen sensing by Metazoans: the central role of the HIF hydroxylase pathway . Mol. Cell Rev.30 ( 04 ), 393 – 402 ( 2008 ).
   PubMedGoogle Scholar
• Cloos PA , ChristensenJ , AggerK , HelinK . Erasing the methyl mark: histone demethylases at the center of cellular differentiation and disease . Genes Dev.22 , 1115 – 1140 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Shilatifard A . Chromatin modifications by methylation and ubiquitination: implications in the regulation of gene expression . Annu. Rev. Biochem.75 , 243 – 269 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Vakoc CR , SachdevaMM , WangH , BlobelGA . Profile of histone lysine methylation across transcribed mammalian chromatin . Mol. Cell. Biol.26 ( 24 ), 9185 – 9195 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Hancock RL , DunneK , WalportLJ , FlashmanE , KawamuraA . Epigenetic regulation by histone demethylases in hypoxia . Epigenomics07 ( 05 ), 791 – 811 ( 2015 ).
   Google Scholar
• Burchfield JS , LiQ , WangHY , WangRF . JMJD3 as an epigenetic regulator in development and disease . Int. J. Biochem. Cell. Biol.67 , 148 – 157 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Yakimchuk K , IravaniM , HasniMSet al. Effect of ligand-activated estrogen receptor β on lymphoma growth in vitro and in vivo . Leukemia25 , 1103 – 1110 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Marzioni M , TorriceA , SaccomannoSet al. An oestrogen receptor β-selective agonist exerts anti-neoplastic effects in experimental intrahepatic cholangiocarcinoma . Dig. Liver Dis.44 , 134 – 142 ( 2012 ).
   PubMedGoogle Scholar
• Pinton G , ManenteAG , DagaAet al. Agonist activation of estrogen receptor beta (ERβ) sensitizes malignant pleural mesothelioma cells to cisplatin . Mol. Cancer13 , 227 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Agger K , CloosPA , ChristensenJet al. UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development . Nature449 ( 7163 ), 731 – 734 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Ivascu A , KubbiesM . Rapid generation of single-tumor spheroids for high-throughput cell function and toxicity analysis . J. Biomol. Screen11 , 922 – 932 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Nagelkerke A , MujcicH , WoutersB , SpanPN . 18S is an appropriate housekeeping gene for in vitro hypoxia experiments . Br. J. Cancer103 ( 04 ), 591 – 592 ( 2010 ).
   Google Scholar
• Higashimura Y , NakajimaY , YamajiRet al. Up-regulation of glyceraldehyde phosphate dehydrogenase gene expression by HIF-activity depending on Sp1 in hypoxic breast cancer cells . Arch. Biochem. Biophys.509 ( 01 ), 01 – 08 ( 2011 ).
   PubMedGoogle Scholar
• Guo X , TianZ , WangXet al. Regulation of histone demethylase KDM6B by hypoxia-inducible factor-2α . Acta Biochim. Biophys. Sin. (Shanghai)47 ( 2 ), 106 – 113 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Francis RJ , SegardT , MorandeauLet al. Characterization of hypoxia in malignant pleural mesothelioma with FMISO PET-CT . Lung Cancer90 ( 1 ), 55 – 60 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Capkova L , KoubkovaL , KodetR . Expression of carbonic anhydrase IX (CAIX) in malignant mesothelioma. An immunohistochemical and immunocytochemical study . Neoplasma61 ( 02 ), 161 – 169 ( 2014 ).
   PubMedGoogle Scholar
• Semenza GL . HIF-1: upstream and downstream of cancer metabolism . Curr. Opin. Genet. Dev.20 , 51 – 56 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Semenza GL . Targeting HIF-1 for cancer therapy . Nat. Rev. Cancer3 , 721 – 732 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Warfel NA , El-DeiryWS . HIF-1 signaling in drug resistance to chemotherapy . Curr. Med. Chem.21 , 3021 – 3028 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Goudarzi H , HidaY , TakanoH , TeramaeH , IizasaH , HamadaJ . Hypoxia affects in vitro growth of newly established cell lines from patients with malignant pleural mesothelioma . Biomed. Res.34 ( 1 ), 13 – 21 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Kaelin WG , RatcliffePJ . Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway . Mol. Cell30 ( 4 ), 393 – 402 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Myllyharju J . Prolyl 4-hydroxylases, master regulators of the hypoxia response . Acta Physiol. (Oxf.)208 ( 2 ), 148 – 165 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Semenza GL . Oxygen sensing, hypoxia-inducible factors, and disease pathophysiology . Annu. Rev. Pathol.9 , 47 – 71 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Jones PA , BaylinSB . The epigenomics of cancer . Cell128 ( 4 ), 682 – 692 ( 2007 ).
   Web of Science ®Google Scholar
• Jaenisch R , YoungR . Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming . Cell132 ( 4 ), 567 – 582 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Kemp CD , RaoM , XiSet al. Polycomb repressor complex-2 is a novel target for mesothelioma therapy . Clin. Cancer Res.18 ( 1 ), 77 – 90 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• LaFave LM , BéguelinW , KocheRet al. Loss of BAP1 function leads to EZH2-dependent transformation . Nat. Med.21 ( 11 ), 1344 – 1349 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Lee HY , ChoiK , OhH , ParkYK , ParkH . HIF-1-dependent induction of Jumonji domain-containing protein (JMJD) 3 under hypoxic conditions . Mol. Cells37 ( 01 ), 43 – 50 ( 2014 ).
   PubMedGoogle Scholar
• Koh MY , PowisG . Passing the baton: the HIF switch . Trends Biochem. Sci.37 ( 09 ), 364 – 372 ( 2012 ).
   PubMedGoogle Scholar
• Chang CJ , YangJY , XiaWet al. EZH2 promotes expansion of breast tumor initiating cells through activation of RAF1-β-catenin signaling . Cancer Cell19 , 86 – 100 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Bao B , AliS , AhmadAet al. Hypoxia induced aggressiveness of pancreatic cancer cells is due to increased expression of VEGF, IL-6 and miR-21, which can be attenuated by CDF treatment . PLoS ONE7 ( 12 ), e50165 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Fleuriel C , ToukaM , BoulayG , GuerardelC , RoodBR , LeprinceD . HIC1 (hypermethylated in cancer 1) epigenetic silencing in tumors . Int. J. Biochem. Cell Biol.41 , 26 – 33 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Wales MM , BielMA , el DeiryWet al. p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3 . Nat. Med.1 , 570 – 577 ( 1995 ).
   PubMed Web of Science ®Google Scholar
• Chen WY , WangDH , YenRC , LuoJ , GuW , BaylinSB . Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses . Cell123 , 437 – 448 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Kemp CD , RaoM , XiSet al. Polycomb repressor complex-2 is a novel target for mesothelioma therapy . Clin. Cancer Res.18 ( 1 ), 77 – 90 ( 2012 ).
   PubMed Web of Science ®Google Scholar